Large B-cell lymphoma with Hodgkin's features.

Area of Science:

• Hematopathology
• Oncology
• Immunology

Background:

• Diffuse large B-cell lymphoma (DLBCL) and Hodgkin's lymphoma (HL) are distinct aggressive lymphoid malignancies.
• Overlap in morphological and immunophenotypic features can occur, posing diagnostic challenges.
• Understanding these intermediate cases is crucial for accurate classification and treatment.

Purpose of the Study:

• To characterize nine cases of DLBCL exhibiting features intermediate with HL.
• To investigate the morphological, immunophenotypic, and molecular characteristics of these unique lymphomas.
• To explore potential pathogenetic mechanisms, including microenvironmental influences.

Main Methods:

• Histopathological analysis of tumor morphology, including cytology and background cellularity.
• Immunophenotypic profiling using a panel of B-cell, Hodgkin's lymphoma, and activation markers.
• Molecular investigations including Epstein-Barr virus (EBV) detection, NF-κB pathway analysis, and gene rearrangement/mutation studies (BCL6, p53).

Main Results:

• Most cases occurred in young males, often as mediastinal tumors.
• Tumors displayed features of both DLBCL and classical HL, including CD30 and CD15 expression alongside a B-cell profile.
• Evidence of NF-κB pathway activation was common; genetic alterations (BCL6 rearrangement, p53 mutation) were observed in a subset.

Conclusions:

• DLBCLs with HL features represent a unique subgroup of aggressive lymphomas.
• Their distinct characteristics may be influenced by the mediastinal microenvironment.
• Further research is warranted to elucidate the specific biology and optimal management of these cases.